Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of zoledronate in erosive hand osteoarthritis
2010-019110-24Phase 2Terminated
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erosive osteoarthritis (EOA) comparing Zoledronate (Aclasta) 5 mg IV with Placebo IV (2 arms). Primary endpoint: AUSCAN pain response at day 90. Started Nov 2010; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
erosive osteoarthritis (EOA)
Beyond the preview
Go deeper on 2010-019110-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019110-24.